23rd World Congress of Dermatology Accepts Miraculins Scientific Poster

Life Science Investing News

Miraculins Inc. (TSXV:MOM) reported that the 23rd World Congress of Dermatology accepted a scientific poster from a collaboration between Miraculins and Amway Corporation’s Open Innovation Team. The poster concludes that advanced glycation end-products (AGE) as measured by the Scout DS® – are correlated with the visible signs of facial skin aging, with vitamin supplementation associated with lower skin AGEs.

Miraculins Inc. (TSXV:MOM) reported that the 23rd World Congress of Dermatology accepted a scientific poster from a collaboration between Miraculins and Amway Corporation’s Open Innovation Team.

The poster concludes that advanced glycation end-products (AGE) as measured by the Scout DS® – are correlated with the visible signs of facial skin aging, with vitamin supplementation associated with lower skin AGEs. The collaborative story described was conducted in the US, on 555 women between 16 to 82 years old, assessed through a cross-sectional survey. The subjects’ skin AGE’s were measured utilizing the Scout DS® device, and facial wrinkling and skin lightness were measured using standardized facial photography and analysis.

As quoted in the press release:

The poster, entitled “The Association of Skin Glycation with Facial Skin Aging”, concludes that advanced glycation end-products (“AGEs”) – as measured by the Scout DS® – are correlated with the visible signs of facial skin aging, and that vitamin supplementation was associated with lower skin AGEs. Miraculins has been reviewing these important pilot findings with Amway to determine the potential next steps in assessing the viability of Scout DS® intellectual property being utilized in a device specifically for the health and beauty segment.

The collaborative study was conducted in the United States on 555 women between the ages of 16 and 82, and was comprised of a mixed race cohort. Subjects were assessed through a cross-sectional survey using objective methods and a questionnaire that took into account age, ethnicity, BMI, smoking, sun protection habits, years working outdoors, vitamin supplementation, skin care habits, tanning, history of type 1 or 2 diabetes, kidney, heart and skin disease. Skin AGE’s were measured utilizing the Scout DS® device, and facial wrinkling and skin lightness were measured using standardized facial photography and analysis.

Click here to read the Miraculins Inc. (TSXV:MOM) press release

Click here to see the Miraculins Inc. (TSXV:MOM) profile.

The Conversation (0)
×